Commission Implementing Regulation (EU) 2022/1998 of 20 September 2022 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Common Customs Tariff
This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.
| CN Code | CAS RN | Name |
|---|---|---|
| 177932-89-7 | (4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(3-aminobenzyl)-5,6-dihydroxyhexahydro-2H-1,3-diazepin-2-one dimethanesulfonate | |
| 178619-89-1 | 6,7-dichloro-2,3-dimethoxyquinoxalin-5-ylamine | |
| 179528-39-3 | N-(biphenyl-2-yl)-4-[(2-methyl-4,5-dihydro-1H-imidazo[4,5-d][1]benzazepin-6-yl)carbonyl]benzamide | |
| 180637-89-2 | 3-[((2R)-1-methylpyrrolidin-2-yl)methyl]-5-[(E)-2-(phenylsulfonyl)vinyl]indole | |
| 180915-94-0 | 1-{2-[4-(6-methoxy-3,4-dihydro-1-naphthyl)phenoxy]ethyl}pyrrolidine | |
| 180915-95-1 | 1-{2-[4-(2-bromo-6-methoxy-3,4-dihydro-1-naphthyl)phenoxy]ethyl}pyrrolidine | |
| 181827-47-4 | [N-(methoxycarbonyl)-L-valyl]-L-proline | |
| 182073-77-4 | N′-[N-methoxycarbonyl-L-valyl]-N-[(S)-3,3,3-trifluoro-1-isopropyl-2-oxopropyl]-L-prolinamide | |
| 185453-89-8 | 7-ethyl-3-[2-(trimethylsilyloxy)ethyl]indole | |
| 188113-71-5 | 1-acetyl-3-[((2R)-1-methylpyrrolidin-2-yl)methyl]-5-[(E)-2-(phenylsulfonyl)vinyl]indole | |
| 188978-02-1 | (4R,5S,6S,7R)-1-[(3-amino-1H-indazol-5-yl)methyl]-4,7-dibenzyl-3-butyl-5,6-dihydroxyhexahydro-2H-1,3-diazepin-2-one | |
| 190791-29-8 | (5R,6S)-6-phenyl-5-[4-(2-pyrrolidinoethoxy)phenyl]-5,6,7,8-tetrahydro-2-naphthol—(-)-tartaric acid (1:1) | |
| 193077-87-1 | [(2S)-7-(2-methoxy-2-oxoethyl)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid | |
| 193274-37-2 | 3a-benzyl-2-methyl-2,3a,4,5,6,7-hexahydro-3H-pyrazolo[4,3-c]pyridin-3-one L-tartrate | |
| 194602-25-0 | dibenzyl 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-(1H-1,2,4-triazol-1-ylmethyl)ethyl phosphate | |
| 194602-27-2 | diphenyl[(S)-pyrrolidin-3-yl]acetonitrile hydrobromide | |
| 197143-35-4 | (3Z)-4-(aminomethyl)pyrrolidin-3-one O-methyloxime dihydrochloride | |
| 204255-02-7 | ethyl (1R,5R,6R)-5-(1-ethylpropoxy)-7-azabicyclo[4.1.0]hept-3-ene-3-carboxylate | |
| 210288-67-8 | [(2S)-7-iodo-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid | |
| 210558-66-0 | (1R,2S)-1-phenyl-2-pyrrolidin-1-ylpropan-1-ol hydrochloride | |
| 219909-83-8 | 3-((4S)-4-sulfanyl-L-prolinamido)benzoic acid hydrochloride | |
| 221030-56-4 | 2-(4-fluorophenyl)-4-(3-hydroxy-3-methylbutoxy)-5-(4-mesylphenyl)pyridazin-3(2H)-one | |
| 221148-46-5 | 2-(4-ethoxyphenyl)-3-(4-mesylphenyl)pyrazolo[1,5-b]pyridazine | |
| 227025-33-4 | 1-benzyl-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one | |
| 235106-62-4 | 2,2′-[(4-hydroxyphenyl)methylene]bis(4-{(E)-[(5-methyl-1H-tetrazol-1-yl)imino]methyl}phenol) | |
| 239463-85-5 | 3-{5-[(2R)-2-aminopropyl]-7-cyano-2,3-dihydro-1H-indol-1-yl}propyl benzoate (2R,3R)-2,3-dihydroxybutanedioate | |
| 244191-95-5 | α-L-aspartyl-N 6-(tert-butoxycarbonyl)-L-lysyl-N 1-(tert-butoxycarbonyl)-L-tryptophyl-L-alanyl-O-tert-butyl-L-seryl-L-leucyl-N 1-(tert-butoxycarbonyl)-L-tryptophyl-N-trityl-L-asparaginyl-N1-(tert-butoxycarbonyl)-L-tryptophyl-L-phenylalaninamide, tert-butyl ester | |
| 244191-96-6 | N-[(9H-fluoren-9-ylmethoxy)carbonyl]-α-L-aspartyl-N 6-(tert-butoxycarbonyl)-L-lysyl-N 1-(tert-butoxycarbonyl)-L-tryptophyl-L-alanyl-O-tert-butyl-L-seryl-L-leucyl-N 1-(tert-butoxycarbonyl)-L-tryptophyl-N-trityl-L-asparaginyl-N 1-(tert-butoxycarbonyl)-L-tryptophan, 1-tert-butyl ester | |
| 244244-29-9 | N-[(9H-fluoren-9-ylmethoxy)carbonyl]-α-L-glutamyl-N 6-(tert-butoxycarbonyl)-L-lysyl-N-trityl-L-asparaginyl-α-L-glutamyl-N-trityl-L-glutaminyl-α-L-glutamyl-L-leucyl-L-leucyl-α-L-glutamyl-L-leucyl-α-L-aspartyl-N 6-(tert-butoxycarbonyl)-L-lysyl-N 1-(tert-butoxycarbonyl)-L-tryptophyl-L-alanyl-O-tert-butyl-L-seryl-L-leucyl-N 1-(tert-butoxycarbonyl)-L-tryptophyl-N-trityl-L-asparaginyl-N 1-(tert-butoxycarbonyl)-L-tryptophyl-L-phenylalaninamide, penta-tert-butyl ester | |
| 244244-31-3 | α-L-glutamyl-N 6-(tert-butoxycarbonyl)-L-lysyl-N-trityl-L-asparaginyl-α-L-glutamyl-N-trityl-L-glutaminyl-α-L-glutamyl-L-leucyl-L-leucyl-α-L-glutamyl-L-leucyl-α-L-aspartyl-N 6-(tert-butoxycarbonyl)-L-lysyl-N 1-(tert-butoxycarbonyl)-L-tryptophyl-L-alanyl-O-tert-butyl-L-seryl-L-leucyl-N 1-(tert-butoxycarbonyl)-L-tryptophyl-N-trityl-L-asparaginyl-N 1-(tert-butoxycarbonyl)-L-tryptophyl-L-phenylalaninamide, penta-tert-butyl ester monohydrochloride | |
| 251579-55-2 | (N-acetyl-N-methylglycyl)glycylvalyl-D-alloisoleucylthreonylnorvalylisoleucylarginyl(N-ethylprolinamide) monoacetate (salt) | |
| 252742-72-6 | 5-(chloromethyl)-1,2-dihydro-3H-1,2,4-triazol-3-one | |
| 259793-88-9 | 6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxamide | |
| 261953-36-0 | 6-iodo-1H-indazole | |
| 269731-84-2 | (5R,6R)-1-benzyl-5-hydroxy-6-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one | |
| 272107-22-9 | 3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridine | |
| 288385-88-6 | 4-fluoro-2-methyl-1H-indol-5-ol | |
| 346412-97-3 | 1-aminopyridazinium hexafluorophosphate(1-) | |
| 361440-67-7 | tert-butyl (1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate | |
| 442526-89-8 | isoleucylarginyl(N-ethylprolinamide) dihydrochloride | |
| 444731-72-0 | 2,3-dimethyl-2H-indazol-6-amine | |
| 481659-93-2 | ethyl 1-methyl-5-[4′-(trifluoromethyl)biphenyl-2-carboxamido]indole-2-carboxylate | |
| 481659-96-5 | potassium 1-methyl-5-[4′-(trifluoromethyl)biphenyl-2-carboxamido]indole-2-carboxylate | |
| 503293-47-8 | 5-(2-chloro-6-fluorophenyl)-2H-tetrazole | |
| 557101-39-0 | ethyl 2-amino-9,10-dimethoxy-1,6,7,11b-tetrahydro-4H-pyrido[2,1-a]isoquinoline-3-carboxylate | |
| 606143-52-6 | 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide | |
| 631916-97-7 | (2S)-N-{4-[(Z)-amino(methoxyimino)methyl]benzyl}-1-{(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyethanoyl}azetidine-2-carboxamide—benzenesulphonic acid (1:1) | |
| 649735-46-6 | (2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-ol | |
| 709031-38-9 | tert-butyl (2S)-2-carbamoyl-2,3-dihydro-1H-pyrrole-1-carboxylate | |
| 709031-43-6 | tert-butyl [(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)-2-oxoethyl]carbamate | |
| 709031-45-8 | (1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate | |
| 796967-16-3 | 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea | |
| 872206-47-8 | 5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate | |
| 912444-00-9 | 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide | |
| 912445-36-4 | 2-[(2S)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide dihydrochloride | |
| 942436-93-3 | 4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamide | |
| 942437-37-8 | 4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propylcinnoline-3-carboxamide | |
| 948846-40-0 | (2S,3S)-2,3-bis[(phenylcarbonyl)oxy]butanedioic acid—ethyl (3aR,6aR)-hexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxylate (1:1) | |
| 952490-01-6 | 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate | |
| 1000164-36-2 | (5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S)-5-(3-amino-3-oxopropyl)-20-benzyl-23-[(2S)-butan-2-yl]-14,38-bis{4-[(tert-butoxycarbonyl)amino]butyl}-29-{[1-(tert-butoxycarbonyl)-1H-indol-3-yl]methyl}-17-(3-tert-butoxy-3-oxopropyl)-1-(1H-fluoren-9-yl)-8,11,26,41,41-pentamethyl-32-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-35-(propan-2-yl)-2-oxa-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaazadotetracontan-42-oic acid | |
| 1137606-74-6 | 6-fluoro-3-oxo-3,4-dihydropyrazine-2-carbonitrile—N-cyclohexylcyclohexanamine (1:1) | |
| 1145655-58-8 | 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea hydrochloride | |
| 1246733-24-3 | methyl 1-tert-butyl-2-hydroxy-1H-pyrrolo[2,3-b]pyridine-3-carboxylate | |
| 1253734-75-6 | 5-fluoro-1-(3-fluorobenzyl)-N-(1H-indol-5-yl)-1H-indole-2-carboxamide | |
| 1256462-18-6 | 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid sulfate | |
| 2934 10 00 | 556-90-1 | 2-imino-1,3-thiazol-4-one |
| 2295-31-0 | thiazolidine-2,4-dione | |
| 29676-71-9 | (2-amino-1,3-thiazol-4-yl)acetic acid | |
| 34272-64-5 | (4-methyl-2-sulfanyl-1,3-thiazol-5-yl)acetic acid | |
| 38585-74-9 | thiazol-5-ylmethanol | |
| 64485-82-1 | ethyl 2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetate | |
| 64485-88-7 | ethyl (Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetate | |
| 64485-90-1 | (Z)-2-methoxyimino-2-[2-(tritylamino)thiazol-4-yl]acetic acid | |
| 64486-18-6 | (Z)-2-[2-(chloroacetamido)thiazol-4-yl]-2-(methoxyimino)acetic acid | |
| 64987-03-7 | ethyl (2-formamido-1,3-thiazol-4-yl)glyoxylate | |
| 64987-06-0 | (2-formamido-1,3-thiazol-4-yl)glyoxylic acid | |
| 65872-41-5 | (Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetic acid | |
| 65872-43-7 | 2-(2-formamido-1,3-thiazol-4-yl)-2-methoxyiminoacetic acid | |
| 66339-00-2 | ethyl 2-(hydroxyimino)-2-[2-(tritylamino)thiazol-4-yl]acetate hydrochloride | |
| 68672-66-2 | (2Z)-{[(1-tert-butoxy-2-methyl-1-oxopropan-2-yl)oxy]imino}[2-(tritylamino)-1,3-thiazol-4-yl]ethanoic acid | |
| 76823-93-3 | 1-{4-[(2-cyanoethyl)thiomethyl]thiazol-2-yl}guanidine | |
| 88023-65-8 | potassium 3-[(2-formamido-1,3-thiazol-4-yl)oxoacetamido]-2-methyl-4-oxoazetidine-1-sulfonate | |
| 88046-01-9 | 2-guanidinothiazol-4-ylmethyl carbamimidothioate dihydrochloride | |
| 102199-36-0 | (2E)-2-(2-{[(benzyloxy)carbonyl]amino}-1,3-thiazol-4-yl)-5-[(3-methylbut-2-en-1-yl)oxy]-5-oxopent-2-enoic acid | |
| 105889-80-3 | pivaloyloxymethyl 7-{(Z)-2-[2-(tert-butoxycarbonylamino)thiazol-4-yl]pent-2-enamido}-3-(carbamoyloxymethyl)-3-cephem-4-carboxylate | |
| 110130-88-6 | (2Z)-(acetyloxy)iminoethanoic acid | |
| 119154-86-8 | (Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl chloride hydrochloride | |
| 127660-04-2 | sodium (2Z)-(2-amino-1,3-thiazol-4-yl)(hydroxyimino)ethanoate | |
| 136401-69-9 | (Z)-5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzylidene}-1,3-thiazolidine-2,4-dione | |
| 139340-56-0 | {5-[(Z)-3,5-di(tert-butyl)-4-hydroxybenzylidene]-4-oxo-4,5-dihydrothiazol-2-yl}ammonium methanesulfonate | |
| 154212-59-6 | 4-nitrophenyl thiazol-5-ylmethyl carbonate hydrochloride | |
| 154212-61-0 | N-[2-isopropylthiazol-4-ylmethyl(methyl)carbamoyl]-L-valine | |
| 161798-03-4 | ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | |
| 162208-27-7 | O-[2-(2-amino-1,3-thiazol-4-yl)-2-((Z)-methoxyimino)acetyl] O,O-diethyl phosphorothioate | |
| 162208-28-8 | O-(2-(2-aminothiazol-4-yl)-2-{[1-(tert-butoxycarbonyl)-1-methylethoxy]imino}acetyl) O′,O″-diethyl phosphorothioate | |
| 171485-87-3 | 2-[4-(2-amino-4-oxo-4,5-dihydrothiazol-5-ylmethyl)phenoxymethyl]-2,5,7,8-tetramethylchroman-6-yl acetate | |
| 174761-17-2 | benzhydryl 7-{(Z)-2-[2-(tert-butoxycarbonylamino)thiazol-4-yl]-4-(3-methylbut-2-enyloxycarbonyl)but-2-enamido}-3-cephem-4-carboxylate | |
| 179258-52-7 | tert-butyl (7Z)-7-(2-amino-1,3-thiazol-5-yl)-4-ethoxy-10,10-dimethyl-6-oxo-3,5,9-trioxa-8-aza-4-phosphaundec-7-en-11-oate 4-oxide | |
| 180144-61-0 | 3-{[4-(4-amidinophenyl)thiazol-2-yl][1-(carboxymethyl)-4-piperidyl]amino}propionic acid | |
| 186538-00-1 | 3-[(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-phenylbutanoyl]-5,5-dimethyl-N-(2-methylbenzyl)-1,3-thiazolidine-4-carboxamide | |
| 189448-35-9 | (7R)-7-[(2E)-2-(2-amino-5-chloro-1,3-thiazol-4-yl)-2-(hydroxyimino)acetamido]-3-[(3-{[(2-aminoethyl)sulfanyl]methyl}pyridin-4-yl)sulfanyl]-3,4-didehydrocepham-4-carboxylic acid | |
| 190841-79-3 | ethyl 3-({4-[4-(N-ethoxycarbonylamidino)phenyl]thiazol-2-yl}[1-(ethoxycarbonylmethyl)-4-piperidyl]amino)propionate | |
| 213252-19-8 | 5-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]-2-methoxy-N-[4-(trifluoromethyl)benzyl]benzamide | |
| 221671-63-2 | potassium (2-{N-[4-(4-chloro-2,5-dimethoxyphenyl)-5-(2-cyclohexylethyl)-1,3-thiazol-2-yl]carbamoyl}-5,7-dimethylindolin-1-yl)acetate | |
| 224631-15-6 | 2,5-dioxopyrrolidin-1-yl N-{N-[(2-isopropyl-1,3-thiazol-4-yl)methyl]-N-methylcarbamoyl}-L-valinate | |
| 291536-35-1 | (5Z)-5-(4-fluorobenzylidene)-1,3-thiazolidine-2,4-dione | |
| 302964-08-5 | N-(2-chloro-6-methylphenyl)-2-[(6-chloro-2-methylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide | |
| 302964-24-5 | 2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide | |
| 478410-84-3 | (4R)-N-allyl-3-[(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-phenylbutanoyl]-5,5-dimethylthiazolidine-4-carboxamide | |
| 752253-39-7 | 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(prop-2-yn-1-yl)-1,3-thiazol-2-amine | |
| 866920-24-3 | 3-[2-chloro-4-({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methoxy)phenyl]-1,2,4-oxadiazol-5(4H)-one | |
| 914361-45-8 | L-lysine—{[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl]oxy}methyl dihydrogen phosphate—ethanol (1:1:1) | |
| 2934 20 80 | 80756-85-0 | S-(benzothiazol-2-yl) (Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminothioacetate |
| 87691-88-1 | 1-(1,2-benzisothiazol-3-yl)piperazine hydrochloride | |
| 89604-92-2 | tert-butyl 2-{[1-(2-aminothiazol-4-yl)-2-(benzisothiazol-2-ylthio)-2-oxoethylidene]aminooxy}-2-methylpropionate | |
| 177785-47-6 | (2S,3S)-3-methyl-2-(3-oxo-2,3-dihydro-1,2-benzisothiazol-2-yl)valeric acid | |
| 2934 30 90 | 92-39-7 | 2-chlorophenothiazine |
| 6631-94-3 | 2-acetylphenothiazine | |
| 32338-15-1 | phenothiazin-2-ylamine | |
| 2934 99 60 | 957-68-6 | 7-aminocephalosporanic acid |
| 2934 99 90 | 50-89-5 | thymidine |
| 58-61-7 | adenosine | |
| 63-37-6 | cytidine 5′-(dihydrogen phosphate) | |
| 98-03-3 | thiophene-2-carbaldehyde | |
| 551-16-6 | 6-aminopenicillanic acid | |
| 940-69-2 | DL-5-(1,2-dithiolan-3-yl)valeramide | |
| 1463-10-1 | 5-methyluridine | |
| 3083-77-0 | 1-(beta-D-arabinofuranosyl)pyrimidine-2,4(1H,3H)-dione | |
| 3158-91-6 | 2-chlorodibenzo[b,f][1,4]oxazepin-11(10H)-one | |
| 4097-22-7 | 2′,3′-dideoxyadenosine | |
| 4295-65-2 | 2-chloro-9-(3-dimethylaminopropyl)-9H-thioxanthen-9-ol | |
| 4462-55-9 | 3-(2,6-dichlorophenyl)-5-methylisoxazole-4-carbonyl chloride | |
| 4691-65-0 | inosine 5′-disodium phosphate | |
| 4923-87-9 | 5-bromo-1-benzothiophene | |
| 5271-67-0 | thiophene-2-carbonyl chloride | |
| 6504-57-0 | 4-[3-hydroxy-3-phenyl-3-(thiophen-2-yl)propyl]-4-methylmorpholin-4-ium methyl sulfate | |
| 7481-90-5 | 1-(3,5-anhydro-2-deoxy-β-D-threo-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione | |
| 13062-59-4 | 4-morpholin-2-ylpyrocatechol hydrochloride | |
| 13636-02-7 | (RS)-3-(dimethylamino)-1-(2-thienyl)propan-1-ol | |
| 14282-76-9 | 2-bromo-3-methylthiophene | |
| 16883-16-2 | 5-methyl-3-phenylisoxazole-4-carbonyl chloride | |
| 17381-54-3 | (1-benzothiophen-5-yl)acetic acid | |
| 18686-82-3 | 1,3,4-thiadiazole-2-thiol | |
| 20893-30-5 | 2-thienylacetonitrile | |
| 21080-92-2 | 3-thienylmalonic acid | |
| 22252-43-3 | 7-amino-3-methyl-3-cephem-4-carboxylic acid | |
| 22720-75-8 | 2-acetylbenzo[b]thiophene | |
| 24209-38-9 | 7-amino-3-(1-methyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid | |
| 24209-43-6 | (7R)-7-amino-3-[2-(1,3,4-thiadiazol-2-ylsulfanyl)ethyl]-3,4-didehydrocepham-4-carboxylic acid | |
| 24683-26-9 | ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide | |
| 24701-69-7 | 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid | |
| 25229-97-4 | 2-cyano-3-morpholinoacrylamide | |
| 25629-50-9 | 3-(2-chlorophenyl)-5-methylisoxazole-4-carbonyl chloride | |
| 25954-21-6 | 5-methyluridine hemihydrate | |
| 26638-53-9 | 3-chloro-6-methyldibenzo[c,f][1,2]thiazepin-11(6H)-one 5,5-dioxide | |
| 27255-72-7 | 3-methyl-7-(phenylacetamido)-3-cephem-4-carboxylic acid | |
| 28092-62-8 | (3aS,6aR)-1,3-dibenzyl-2,3,3a,4,6,6a-hexahydro-1H-furo[3,4-d]imidazole-2,4-dione | |
| 28657-79-6 | 1-ethyl-1,4-dihydro-4-oxo-1,3-dioxolo[4,5-g]cinnoline-3-carbonitrile | |
| 28783-41-7 | 4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride | |
| 29490-19-5 | 5-methyl-1,3,4-thiadiazole-2-thiol | |
| 29706-84-1 | 3′-azido-3′-deoxy-5′-O-tritylthymidine | |
| 29707-62-8 | 4-nitrobenzyl 6-(2-phenoxyacetamido)penicillanate 1-oxide | |
| 30165-96-9 | 4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine | |
| 30246-33-4 | 7-amino-3-[(5-methyl-1,3,4-thiadiazol-2-yl)thiomethyl]-3-cephem-4-carboxylic acid | |
| 32231-06-4 | 1-piperonylpiperazine | |
| 36923-17-8 | (7R)-7-amino-3,4-didehydrocepham-4-carboxylic acid | |
| 37539-03-0 | (7R)-7-amino-3-[(1H-1,2,3-triazol-4-ylsulfanyl)methyl]-3,4-didehydrocepham-4-carboxylic acid | |
| 38313-48-3 | 3′,5′-anhydrothymidine | |
| 39098-97-0 | 2-thienylacetyl chloride | |
| 39754-02-4 | 7-[(R)-amino(phenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid—dimethylformamide (2:1) | |
| 39925-10-5 | methyl 1-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxylate | |
| 40172-95-0 | 1-(2-furoyl)piperazine | |
| 42399-49-5 | (2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one | |
| 51762-51-7 | benzhydryl 3-hydroxy-7-(phenylacetamido)cepham-4-carboxylate | |
| 51818-85-0 | 7-[(D)-mandelamido]cephalosporanic acid | |
| 53994-69-7 | (7R)-7-amino-3-chloro-3,4-didehydrocepham-4-carboxylic acid | |
| 53994-83-5 | 4-nitrobenzyl 7-amino-3-chloro-3-cephem-4-carboxylate | |
| 55612-11-8 | 5′-O-tritylthymidine | |
| 59337-92-7 | methyl 3-(chlorosulfonyl)thiophene-2-carboxylate | |
| 59804-25-0 | methyl 4-hydroxy-2-methyl-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-dioxide | |
| 61807-78-1 | 7-(bromoacetamido)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid | |
| 63074-07-7 | 1-(tetrahydro-2-furoyl)piperazine | |
| 63427-57-6 | 4-nitrobenzyl 3-methylene-7-(phenoxyacetamido)cepham-4-carboxylate 5-oxide | |
| 63457-21-6 | diphenylmethyl 2-(3-benzyl-7-oxo-4-thia-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)-3-methylbut-3-enoate | |
| 63675-74-1 | 6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene | |
| 63877-96-3 | 2-(4-fluorobenzyl)thiophene | |
| 67914-85-6 | cis-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-ylmethanol | |
| 67978-05-6 | diphenylmethyl (2R)-3-methyl-2-[(1R,5S)-3-(4-methylphenyl)-7-oxo-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl]but-3-enoate | |
| 68350-02-7 | (7R)-7-amino-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid hydrochloride | |
| 69399-79-7 | 3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carbonyl chloride | |
| 70035-75-5 | diphenylmethyl (7S)-7-(bromoacetamido)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylate | |
| 70918-74-0 | 1-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazine hydrochloride | |
| 71420-85-4 | 7-amino-3-[1-(sulfomethyl)-1H-tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acid, sodium salt | |
| 75776-79-3 | 1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid hydrobromide | |
| 76247-39-7 | iodomethyl penicillanate 1,1-dioxide | |
| 76646-91-8 | (3S)-6,6-dibromo-2,2-dimethylpenam-3-carboxylic acid 1,1-dioxide | |
| 76801-85-9 | (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-{[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-15-one | |
| 77887-68-4 | benzhydryl 6-(4-methylbenzamido)penicillanate 4-oxide | |
| 78850-37-0 | methyl (3aR,4R,7aR)-2-methyl-4-[(1S,2R)-1,2,3-triacetoxypropyl]-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate | |
| 79349-82-9 | trans-(7R)-7-amino-3-vinyl-3,4-didehydrocepham-4-carboxylic acid | |
| 80370-59-8 | 7-amino-3-(2-furoylthiomethyl)-3-cephem-4-carboxylic acid | |
| 84682-23-5 | 2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-ylmethanol | |
| 84793-24-8 | ethyl (S)-2-[(S)-4-methyl-2,5-dioxo-1,3-oxazolidin-3-yl]-4-phenylbutyrate | |
| 84915-43-5 | (3S)-2,2-dimethyl-1,4-thiazinane-3-carboxylic acid | |
| 85006-31-1 | methyl 3-amino-4-methylthiophene-2-carboxylate | |
| 86639-52-3 | (4S)-4,11-diethyl-4,9-dihydroxy-1H,12H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | |
| 87932-78-3 | 3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-3-cephem-4-carboxylic acid | |
| 92096-37-2 | diphenylmethyl (7R)-3-(mesyloxy)-7-(phenylacetamido)-3,4-didehydrocepham-4-carboxylate | |
| 93183-15-4 | 2′-deoxy-5′-O-(4,4′-dimethoxytrityl)-N 2-isobutyrylguanosine 3′-(2-cyanoethyl diisopropylphosphoramidite) | |
| 94732-98-6 | 1-(1-{3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl}-4-piperidyl)-2,3-dihydro-1H-benzimidazole-2-thione | |
| 96219-87-3 | (3-aminopyrazol-4-yl)(2-thienyl)methanone | |
| 96803-30-4 | 2-(1-benzothiophen-5-yl)ethanol | |
| 98796-51-1 | 2′-deoxy-5′-O-(4,4′-dimethoxytrityl)thymidine 3′-(2-cyanoethyl diisopropylphosphoramidite) | |
| 98796-53-3 | N 6-benzoyl-2′-deoxy-5′-O-(4,4′-dimethoxytrityl)adenosine 3′-(2-cyanoethyl diisopropylphosphoramidite) | |
| 100988-63-4 | 1-[((7R)-7-amino-4-carboxy-3,4-didehydrocepham-3-yl)methyl]pyridinium iodide | |
| 102212-98-6 | N 4-benzoyl-2′-deoxy-5′-O-(4,4′-dimethoxytrityl)cytidine 3′-(2-cyanoethyl diisopropylphosphoramidite) | |
| 103788-59-6 | 4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzaldehyde | |
| 103788-65-4 | 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethan-1-ol | |
| 104146-10-3 | 4-methoxybenzyl 3-chloromethyl-7-(2-phenylacetamido)-3-cephem-4-carboxylate | |
| 104218-44-2 | 3′-O-mesyl-5′-O-tritylthymidine | |
| 104795-66-6 | 3-isopropoxy-5-methoxy-N-(1H-tetrazol-5-yl)benzo[b]thiophene-2-carboxamide | |
| 104795-67-7 | 3-isopropoxy-5-methoxy-N-(1H-tetrazol-5-yl)benzo[b]thiophene-2-carboxamide-1H-imidazole (1:1) | |
| 104795-68-8 | 3-isopropoxy-5-methoxy-N-(1H-tetrazol-5-yl)benzo[b]thiophene-2-carboxamide, sodium salt | |
| 106447-44-3 | 7-amino-3-[(Z)-prop-1-enyl]-3-cephem-4-carboxylic acid | |
| 108895-45-0 | 3′-azido-2′,3′-dideoxy-5-methylcytidine hydrochloride | |
| 110314-42-6 | 5-[(benzofuran-2-ylcarbonyl)amino]indole-2-carboxylic acid | |
| 110351-94-5 | (S)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione | |
| 110483-43-7 | 2′-bromo-2′-deoxy-5-methyluridine 3′,5′-diacetate | |
| 112913-94-7 | N-{[4-(4-fluorobenzyl)morpholin-2-yl]methyl}acetamide | |
| 113891-01-3 | diphenylmethyl (2S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4-oxide | |
| 114341-88-7 | 3-(2-bromopropanoyl)-4,4-dimethyl-1,3-oxazolidin-2-one | |
| 115787-67-2 | 2-(2-amino-5-nitro-6-oxo-1,6-dihydropyrimidin-4-yl)-3-(3-thienyl)propiononitrile | |
| 116539-55-0 | (1S)-3-(methylamino)-1-(2-thienyl)propan-1-ol | |
| 116833-10-4 | (Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-[(fluoromethoxy)imino]acetic acid | |
| 117829-20-6 | 2-amino-7-thenyl-1,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one hydrochloride | |
| 119221-49-7 | 5-[(2-aminoethyl)amino]-2-(2-diethylaminoethyl)-2H-[1]benzothiopyrano[4,3,2-cd]indazol-8-ol | |
| 120788-03-6 | S-[(1R,3S)-1-oxidotetrahydrothiophen-3-yl] ethanethioate | |
| 122567-97-9 | 5′-benzoyl-2′,3′-didehydro-3′-deoxythymidine | |
| 124492-04-2 | (S)-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid | |
| 125995-03-1 | (4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl}-4-hydroxytetrahydro-2H-pyran-2-one | |
| 126429-09-2 | 2-(dichloromethyl)-4,5-dihydro-5-(4-mesylphenyl)oxazol-4-ylmethanol | |
| 126813-11-4 | (4R,5R)-2-(dichloromethyl)-4,5-dihydro-5-(4-mesylphenyl)oxazol-4-ylmethanol | |
| 127000-90-2 | 1-{[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazole | |
| 127111-98-2 | diphenylmethyl (7R)-7-amino-3-(mesyloxy)-3,4-didehydrocepham-4-carboxylate hydrochloride | |
| 130209-90-4 | methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)acetate hydrochloride | |
| 130800-76-9 | 5-(3-chloropropyl)-3-methylisoxazole | |
| 131986-28-2 | 3-(4-chloro-1,2,5-thiadiazol-3-yl)pyridine | |
| 131988-19-7 | 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1-methylpyridinium iodide | |
| 132335-44-5 | (S)-3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol | |
| 132335-46-7 | (3S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine | |
| 133413-70-4 | (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-4,10,12,16,22,24-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosane-2,5,8,11,14,17,20,23-octone | |
| 135790-89-5 | [(2,2-dimethylpropanoyl)oxy]methyl (7R)-7-[(2Z)-2-(2-{(2S)-2-[(tert-butoxycarbonyl)amino]propanamido}-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3,4-didehydrocepham-4-carboxylate | |
| 138564-59-7 | 5-methyl-2-(2-nitroanilino)thiophene-3-carbonitrile | |
| 140128-37-6 | diphenylmethyl (7R)-7-(2-{2-[(tert-butoxycarbonyl)amino]-1,3-thiazol-4-yl}-2-[(trityloxy)imino]acetamido)-3-({[(1H-1,2,3-triazol-4-yl)sulfanyl]methyl}sulfanyl)-3,4-didehydrocepham-4-carboxylate | |
| 140841-32-3 | 6-[3-fluoro-5-(4-methoxytetrahydropyran-4-yl)phenoxymethyl]-1-methyl-2-quinolone | |
| 143468-96-6 | ethyl hydrogen (2-thienylmethyl)malonate | |
| 147027-10-9 | (1R,2S,5R)-menthyl (2R,5S)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-1,3-oxathiolane-2-carboxylate | |
| 147086-81-5 | (4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol 7,7-dioxide | |
| 147086-83-7 | N-[(4S,6S)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl]acetamide | |
| 147126-62-3 | (1R,2S,5R)-menthyl (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylate | |
| 152305-23-2 | (S)-4-(4-aminobenzyl)oxazolidin-2-one | |
| 155990-20-8 | N-[(1-{[2-(diethylamino)ethyl]amino}-7-methoxy-9-oxo-9H-thioxanthen-4-yl)methyl]formamide | |
| 157341-41-8 | (2S)-N-[(R)-1-(1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2-{4-[(4-methylpiperazin-1-yl)carbonyl]phenoxy}-4-oxoazetidine-1-carboxamide | |
| 158512-24-4 | (3aS,8aR)-3-[(2R,4S)-2-benzyl-4,5-epoxyvaleryl]-2,2-dimethyl-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazole | |
| 158878-46-7 | 6-{(E)-2-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl]vinyl}-4-hydroxytetrahydro-2H-pyran-2-one | |
| 160115-08-2 | {(E)-3-[(6R,7R)-7-amino-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]allyl}(carbamoylmethyl)(ethyl)methylammonium | |
| 161005-84-1 | (S)-N,N-dimethyl-[3-(2-thienyl)-3-(1-naphthyloxy)propyl]amine—phosphoric acid (1:1) | |
| 161599-46-8 | (2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-2-fluoro-5-methyltetrahydrofuran-3,4-diyl diacetate | |
| 163680-80-6 | (3S)-10-[1-(acetylamino)cyclopropyl]-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid | |
| 164015-32-1 | N-methyl-3-(1-naphthyloxy)-2-(2-thienyl)propan-1-amine phosphate | |
| 165172-60-1 | 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione—1-methylpyrrolidin-2-one (1:1) | |
| 166964-09-6 | 4-chloro-3-methyl-1,2-oxazol-5-amine | |
| 167304-98-5 | methyl (4S,7S,10aS)-4-amino-5-oxooctahydro-7H-pyrido[2,1-b][1,3]thiazepine-7-carboxylate | |
| 168828-81-7 | benzyl (3-fluoro-4-morpholinophenyl)carbamate | |
| 170985-86-1 | 1-[(2S,3S)-2-(benzyloxy)pentan-3-yl]-4-(4-{4-[4-({(3R,5R)-5-(2,4-difluorophenyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]tetrahydrofuran-3-yl}methoxy)phenyl]piperazin-1-yl}phenyl)-1H-1,2,4-triazol-5(4H)-one | |
| 171482-05-6 | (2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholine hydrochloride | |
| 175712-02-4 | [(3S,5S)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-yl]methyl 4-chlorobenzenesulfonate | |
| 176773-87-8 | (3R)-3-(methoxymethyl)-7-(4,4,4-trifluorobutoxy)-3,3a,4,5-tetrahydro[1,3]oxazolo[3,4-a]quinolin-1-one | |
| 177575-17-6 | (S)-N-{5-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-1H-pyrimido[5,4-b][1,4]thiazin-6-yl)ethyl]-2-thenoyl}-L-glutamic acid | |
| 177575-19-8 | diethyl N-{5-[2-((6S)-2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b][1,4]thiazin-6-yl)ethyl]-2-thenoyl}-L-glutamate | |
| 177587-08-5 | N-{5-[2-((6S)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl)ethyl]-4-methylthiophene-2-carbonyl}-L-glutamic acid | |
| 178357-37-4 | (5aR,11bS)-9,10-dimethoxy-2-propyl-4,5,5a,6,7,11b-hexahydrobenzo[f]thieno[2,3-c]quinoline hydrochloride | |
| 181640-09-5 | 3-(1-{2-[4-benzoyl-2-(3,4-difluorophenyl)morpholin-2-yl]ethyl}-4-phenylpiperidin-4-yl)-1,1-dimethylurea hydrochloride | |
| 181696-73-1 | 5-methyl-3,4-diphenyl-4,5-dihydroisoxazol-5-ol | |
| 182133-09-1 | 6-(benzyloxy)-3-bromo-2-(4-methoxyphenyl)-1-benzothiophene 1-oxide | |
| 183433-66-1 | [6-chloro-4-(2-ethyl-1,3-dioxolan-2-yl)-2-methoxypyridin-3-yl]methanol | |
| 183434-04-0 | tert-butyl (4S)-4-ethyl-4,6-dihydroxy-3,10-dioxo-3,4,8,10-tetrahydro-1H-pyrano[3,4-f]indolizine-7-carboxylate | |
| 185835-97-6 | (5S)-5-(methoxymethyl)-3-[6-(4,4,4-trifluorobutoxy)-1,2-benzoxazol-3-yl]-1,3-oxazolidin-2-one | |
| 186256-67-7 | (3S,10R,13Z,16S)-10-(3-chloro-4-methoxybenzyl)-3-isobutyl-6,6-dimethyl-16-[(1S)-1-((2R,3R)-3-phenyloxiran-2-yl)ethyl]-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone | |
| 186348-69-6 | 7-chloro-8-[((2R)-1,4-diazabicyclo[2.2.2]octan-2-yl)methylamino]-2,3-dihydro-1,4-benzodioxine-5-carboxamide | |
| 186521-38-0 | ethyl 5-[(3R)-4-(tert-butoxycarbonylamino)-3-hydroxybutyl]thiophene-2-carboxylate | |
| 186521-39-1 | ethyl 5-[(3R)-4-(tert-butoxycarbonylamino)-3-(mesyloxy)butyl]thiophene-2-carboxylate | |
| 186521-40-4 | ethyl 5-[(3S)-3-(acetylthio)-4-(tert-butoxycarbonylamino)butyl]thiophene-2-carboxylate | |
| 186521-41-5 | dimethyl 2-[(S)-1-(tert-butoxycarbonylaminomethyl)-2-(5-ethoxycarbonyl-2-thienyl)propylthio]malonate | |
| 186521-42-6 | methyl (S)-6-{2-[5-(ethoxycarbonyl)-2-thienyl]ethyl}-3-oxo-1,4-thiazinane-2-carboxylate | |
| 186521-44-8 | ethyl (6S)-5-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b][1,4]thiazin-6-yl)ethyl]thiophene-2-carboxylate | |
| 186521-45-9 | (6S)-5-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b][1,4]thiazin-6-yl)ethyl]thiophene-2-carboxylic acid | |
| 188016-51-5 | methyl N-(butoxycarbonyl)-3-{[(5R)-3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl]acetamido}-L-alaninate | |
| 189028-95-3 | (4S)-3-[(5R)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one | |
| 191023-43-5 | 5-(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-3-(1-phenethylpiperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one | |
| 192049-49-3 | 4-nitrobenzyl 2-((1R,5R)-3-benzyl-7-oxo-4-thia-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)-3-methylbut-2-enoate | |
| 194861-99-9 | ((5S)-3-tert-butyl-2-phenyl-1,3-oxazolidin-5-yl)methanol | |
| 195708-14-6 | (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-3-(ethoxycarbonyl)-2-(4-methoxyphenyl)pyrrolidinium (2S)-hydroxy(phenyl)acetate | |
| 197897-11-3 | 1-[((7R)-7-amino-4-carboxy-3,4-didehydrocepham-3-yl)methyl]-1H-imidazo[1,2-b]pyridazin-4-ium iodide | |
| 199327-61-2 | 7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one | |
| 208337-82-0 | ethyl 5-(but-3-enyl)thiophene-2-carboxylate | |
| 208337-83-1 | ethyl 5-[(3R)-3,4-dihydroxybutyl]thiophene-2-carboxylate | |
| 208337-84-2 | ethyl 5-[(3R)-4-amino-3-hydroxybutyl]thiophene-2-carboxylate | |
| 220099-91-2 | (2R)-3′H-spiro[4-azabicyclo[2.2.2]octane-2,2′-furo[2,3-b]pyridine] | |
| 220100-81-2 | (2R)-3′H-spiro[4-azabicyclo[2.2.2]octane-2,2′-furo[2,3-b]pyridine] (S,S)-2,3-dihydroxybutanedioate | |
| 220997-99-9 | (5R)-9-chloro-5-ethyl-5-hydroxy-10-methyl-12-[(4-methylpiperidin-1-yl)methyl]-1,4,5,13-tetrahydro-3H,15H-oxepino[3′,4′:6,7]indolizino[1,2-b]quinoline-3,15-dione hydrochloride | |
| 221054-70-2 | (5R)-5-ethyl-5-hydroxy-1,4,5,8-tetrahydrooxepino[3,4-c]pyridine-3,9-dione | |
| 223570-85-2 | 8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2,3-dihydropyrazolo[1,5,4-de][1,4]benzoxazine-6-carboxylate | |
| 223595-20-8 | (1R)-5-(1,3,6,2-dioxazaborocan-2-yl)-1-methyl-2-tritylisoindoline | |
| 227029-27-8 | 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl methanesulfonate | |
| 227625-35-6 | 3-{[2-(aminomethyl)cyclohexyl]methyl}-1,2,4-oxadiazol-5(4H)-one | |
| 227626-65-5 | tert-butyl N-methyl-N-{2-[(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)methyl]cyclohexyl}carbamate | |
| 227626-75-7 | 3-{[2-(aminomethyl)cyclohexyl]methyl}-1,2,4-oxadiazol-5(4H)-one hydrochloride | |
| 229336-92-9 | 3-chloro-N-{4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl}-4-{[2-(methylamino)imidazol-1-yl]methyl}thiophene-2-carboxamide | |
| 229340-73-2 | 3-chloro-N-{4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl}-4-{[2-(methylamino)imidazol-1-yl]methyl}thiophene-2-carboxamide trifluoroacetate | |
| 252317-48-9 | {(3S)-1-[1-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}diphenylacetonitrile | |
| 253450-09-8 | 6-({2-[4-(4-fluorobenzyl)piperidin-1-yl]ethyl}sulfinyl)-1,3-benzoxazol-2(3H)-one | |
| 253450-12-3 | 6-{[2-(4-benzylpiperidin-1-yl)ethyl]sulfinyl}-1,3-benzoxazol-2(3H)-one | |
| 265121-04-8 | (3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(2-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid—1-deoxy-1-(methylamino)-D-glucitol (1:2) | |
| 287737-72-8 | (2S)-hydroxy(phenyl)acetic acid—(1S)-3-(dimethylamino)-1-(2-thienyl)propan-1-ol (1:1) (salt) | |
| 287930-73-8 | 4-benzyl-2-hydroxymorpholin-3-one | |
| 287930-75-0 | (2R)-4-benzyl-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}morpholin-3-one | |
| 345217-03-0 | 2-[(2S,3S)-2-(benzyloxy)pentan-3-yl]-4-(4-{4-[4-({(3R,5R)-5-(2,4-difluorophenyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]tetrahydrofuran-3-yl}methoxy)phenyl]piperazin-1-yl}phenyl)semicarbazide | |
| 356782-84-8 | 3-oxo-4-(β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide | |
| 362543-73-5 | DNA, d(P-thio) (C-T-A-G-A-T-T-T-C-C-C-G-C-G), tridecasodium salt | |
| 376608-74-1 | 2-{[(3aR,4S,6R,6aS)-6-{[5-amino-6-chloro-2-(propylsulfanyl)pyrimidin-4-yl]amino}-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy}ethanol | |
| 388082-75-5 | 5-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde 4-methylbenzenesulfonate (1:1) | |
| 390800-88-1 | N,N′,N″-(boroxin-2,4,6-triyltris{[(1S)-3-methylbutane-1,1-diyl]imino[(2S)-1-oxo-3-phenylpropane-1,2-diyl]})tripyrazine-2-carboxamide | |
| 452339-73-0 | (5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one | |
| 474554-48-8 | 2-bromo-1-[3-tert-butyl-4-methoxy-5-(morpholin-4-yl)phenyl]ethanone | |
| 475480-88-7 | 4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophene-7-carbaldehyde | |
| 499785-81-8 | 3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide | |
| 503068-36-8 | (5R)-3-(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one | |
| 519187-97-4 | 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-3-azetidinol (2Z)-2-butenedioate (1:1) | |
| 519188-42-2 | 3-[2-(1-benzothiophen-5-yl)ethoxy]propionic acid | |
| 519188-55-7 | 3-[2-(1-benzothiophen-5-yl)ethoxy]-1-(3-hydroxyazetidin-1-yl)propan-1-one | |
| 521266-46-6 | (2S)-1-{N-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl]glycyl}pyrrolidine-2-carbonitrile | |
| 530141-72-1 | 3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-[(3-hydroxy-1,2-benzoxazol-6-yl)methoxy]phenyl)propanoic acid | |
| 630100-90-2 | (1R)-1,2-anhydro-4-C-{(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-carboxylato-4-cycloheptylpiperazin-2-yl)-6,9-dihydroxy-2,6-dimethyl-11-oxooxacyclododec-3-en-1-yl]penta-1,3-dien-1-yl}-3,5-dideoxy-1-[(2R,3S)-3-hydroxypentan-2-yl]-D-erythropentitol | |
| 635724-55-9 | (2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine succinate | |
| 649761-25-1 | methyl N-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzyl}glycinate hydrochloride | |
| 655233-39-9 | 4-nitrobenzyl (7R)-7-amino-3-((2S)-tetrahydrofuran-2-yl)-3,4-didehydrocepham-4-carboxylate hydrochloride or 4-nitrobenzyl (6R,7R)-7-amino-8-oxo-3-[(2S)-tetrahydrofuran-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride | |
| 663603-70-1 | (2Z)-3-(methylamino)-1-(2-thienyl)prop-2-en-1-one | |
| 665058-78-6 | DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-A-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-T-sp-C-G-sp-T-sp-T) | |
| 690270-65-6 | (2R,3S,4R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido-2-{[(2-methylpropanoyl)oxy]methyl}tetrahydrofuran-3,4-diyl bis(2-methylpropanoate) hydrochloride | |
| 710281-33-7 | 2-({[(1R,3S)-3-{[2-(3-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methoxy}cyclohexyl]oxy}methyl)-6-methylbenzoic acid | |
| 744239-10-9 | DNA, d(P-thio) (G-A-T-C-C-G-C-G-G-G-A-A-A-T), tridecasodium salt | |
| 753015-42-8 | 3-{(E)-2-[(3R)-pyrrolidin-3-yl]ethenyl}-5-(tetrahydro-2H-pyran-4-yloxy)pyridine | |
| 812647-80-6 | {(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-bis[(phenylcarbonyl)oxy]tetrahydrofuran-2-yl}methyl 3-chlorobenzoate | |
| 871484-32-1 | 4-[4-({3-[(4-deoxy-4-fluoro-β-D-glucopyranosyl)oxy]-5-(propan-2-yl)-1H-pyrazol-4-yl}methyl)phenyl]-N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]butanamide | |
| 872728-82-0 | N-[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]glycine | |
| 877130-28-4 | (6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-one | |
| 888504-28-7 | potassium 5-methyl-1,3,4-oxadiazole-2-carboxylate | |
| 893428-72-3 | N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine (2E)-2-butenedioate (1:2) | |
| 913695-00-8 | 2-[({4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethylpyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole, sodium salt (1:1) | |
| 923591-06-4 | methyl (5R,7S,10S)-10-tert-butyl-15,15-dimethyl-3,9,12-trioxo-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-1H,5H-2,23:5,8-dimethano-4,13,2,8,11-benzodioxatriazacyclohenicosine-7(3H)-carboxylate | |
| 947408-94-8 | 6-methyl-2-trityl-1,2-benzoxazol-3(2H)-one | |
| 947408-95-9 | 6-(bromomethyl)-2-triphenylmethyl-1,2-benzisoxazol-3(2H)-one | |
| 947409-01-0 | methyl 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on-6-yl)methoxy]phenyl]propionate | |
| 1001859-46-6 | DNA (synthetic plasmid vector pCOR human interferon beta signal peptide fusion protein with 21-154-human acidic fibroblast growth factor-specifying) | |
| 1029716-44-6 | 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | |
| 1256445-67-6 | (4S,5S)-5-benzyl-2-oxo-1,3-oxazolidin-4-ylmethyl 4-nitrobenzenesulfonate | |
| 1256462-17-5 | (1R,2S,3S,6R)-[(S)-1-phenylethyl]-3,6-epoxytetrahydrophthalimide | |
| 1403828-58-9 | 1-(1-{4-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]butyl}-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one | |
| 2935 90 90 | 121-30-2 | 4-amino-6-chlorobenzene-1,3-disulfonamide |
| 6292-59-7 | 4-tert-butylbenzenesulfonamide | |
| 6973-09-7 | 5-amino-2-methylbenzenesulfonamide | |
| 16673-34-0 | N-(2-(4-sulfamoyl)phenyl)ethyl-5-chloro-2-methoxybenzamide | |
| 17852-52-7 | 4-hydrazonobenzenesulfonamide hydrochloride | |
| 22663-37-2 | 1-(4-chlorobenzenesulfonyl)urea | |
| 24310-36-9 | 1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | |
| 33045-52-2 | methyl 5-sulfamoyl-o-anisate | |
| 33288-71-0 | 5-methyl-N-[4-(sulfamoyl)phenethyl]pyrazine-2-carboxamide | |
| 39570-96-2 | (2R)-3-(benzylsulfanyl)-N-[(2S)-1-{[(2S,3S)-1-hydrazinyl-3-methyl-1-oxopentan-2-yl]amino}-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-2-{[(4-methylphenyl)sulfonyl]amino}propanamide | |
| 66644-80-2 | 3-methoxy-5-sulfamoyl-o-anisic acid | |
| 81880-96-8 | N-(4-hydrazinobenzyl)methanesulfonamide hydrochloride | |
| 84522-34-9 | sodium 4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulfonamide | |
| 88918-84-7 | 4-aminobenzyl-N-methylmethanesulfonamide hydrochloride | |
| 88919-22-6 | 3-(2-aminoethyl)-N-methylindol-5-ylmethanesulfonamide | |
| 88933-16-8 | 1-(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride | |
| 100632-57-3 | 4-[4-(mesylamino)phenyl]-4-oxobutyric acid | |
| 105951-31-3 | 5,6-dihydro-4-oxo-4H-thieno[2,3-b]thiine-2-sulfonamide | |
| 105951-35-7 | 5,6-dihydro-4-oxo-4H-thieno[2,3-b]thiine-2-sulfonamide 7,7-dioxide | |
| 106820-63-7 | methyl 3-[(methoxycarbonylmethyl)sulfamoyl]thiophene-2-carboxylate | |
| 112101-81-2 | 5-[(R)-(2-aminopropyl)]-2-methoxybenzenesulfonamide | |
| 120298-38-6 | N-(5,6-dihydro-6-methyl-2-sulfamoyl-4H-thieno[2,3-b]thiopyran-4-yl)acetamide 7,7-dioxide | |
| 123664-84-6 | N-(5-methoxy-2-phenoxyphenyl)methanesulfonamide | |
| 137431-02-8 | N-[3-(2-amino-1-hydroxyethyl)-4-fluorophenyl]methanesulfonamide | |
| 141430-65-1 | N-[2-(4-hydroxyanilino)pyridin-3-yl]-4-methoxybenzene-1-sulfonamide | |
| 141450-48-8 | N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-methoxybenzenesulfonamide hydrochloride | |
| 147200-03-1 | N-[(4S,6S)-6-methyl-7,7-dioxo-2-sulfamoyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl]acetamide | |
| 149456-98-4 | N-[4-(N-formylglycyl)-5-methoxy-2-phenoxyphenyl]methanesulfonamide | |
| 149457-03-4 | N-[4-(N-formylglycyl)-5-hydroxy-2-phenoxyphenyl]methanesulfonamide | |
| 149490-60-8 | N-(butane-1-sulfonyl)-L-tyrosine | |
| 149490-61-9 | N-(butane-1-sulfonyl)-O-(4-pyridin-4-ylbutyl)-L-tyrosine | |
| 150975-95-4 | 5-methanesulfonamidoindole-2-carboxylic acid | |
| 151140-66-8 | (4-amino-3-iodophenyl)-N-methylmethanesulfonamide | |
| 160231-69-6 | (3S)-tetrahydrofuran-3-yl N-[(2S,3R)-3-hydroxy-4-(N-isobutyl-4-nitrobenzene-1-sulfonamido)-1-phenylbutan-2-yl]carbamate | |
| 169280-56-2 | 4-amino-N-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-isobutylbenzene-1-sulfonamide | |
| 179524-67-5 | (S)-2-{3-[(2-fluorobenzyl)sulfonylamino]-2-oxo-2,3-dihydro-1-pyridyl}-N-(1-formyl-4-guanidinobutyl)acetamide | |
| 183556-68-5 | (S)-N-{(1S,2R)-3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}-3,3-dimethyl-2-(sarcosylamino)butyramide | |
| 189814-01-5 | 3-(2-amino-1-hydroxyethyl)-4-methoxybenzene-1-sulfonamide | |
| 192329-83-2 | (3S)-2,2-dimethyl-4-[4-(4-pyridyloxy)phenylsulfonyl]-1,4-thiazinane-3-carboxylic acid | |
| 193686-76-9 | 7-chloro-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | |
| 194602-23-8 | 2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]benzoic acid | |
| 198470-85-8 | N-[4-(5-methyl-3-phenylisoxazol-4-yl)phenylsulfonyl]propionamide, sodium salt | |
| 200575-15-1 | 4-[2-ethoxy-5-(4-methylpiperazine-1-sulfonyl)benzamido]-1-methyl-3-propylpyrazole-5-carboxamide | |
| 210538-75-3 | N-(1,2,3,4-tetrahydroisoquinolin-5-yl)methanesulfonamide hydrochloride | |
| 244634-31-9 | N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzene-1-sulfonamide hydrochloride | |
| 247582-73-6 | 2-ethoxy-5-(4-ethylpiperazine-1-sulfonyl]nicotinic acid | |
| 289042-10-0 | N-{5-[(diphenylphosphoryl)methyl]-4-(4-fluorophenyl)-6-(propan-2-yl)pyrimidin-2-yl}-N-methylmethanesulfonamide | |
| 289042-12-2 | (4R,6S)-6-((E)-2-{4-(4-fluorophenyl)-6-isopropyl-2-[mesyl(methyl)amino]pyrimidin-5-yl}vinyl)-2,2-dimethyl-1,3-dioxan-4-yl 3,3-dimethylbutanoate | |
| 334826-98-1 | 5-[2-ethoxy-5-(4-ethylpiperazine-1-sulfonyl)pyridin-3-yl]-3-ethyl-2-(2-methoxyethyl)-2,6-dihydropyrazolo[4,3-d]pyrimidin-7-one | |
| 334827-99-5 | 5-[2-ethoxy-5-(4-ethylpiperazine-1-sulfonyl)pyridin-3-yl]-3-ethyl-2-(2-methoxyethyl)-2,3,4,5,6,7-hexahydropyrazolo[4,3-d]pyrimidin-7-one 4-methylbenzene-1-sulfonate | |
| 334828-19-2 | N-[3-carbamoyl-5-ethyl-1-(2-methoxyethyl)pyrazol-4-yl]-2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]nicotinamide | |
| 364321-71-1 | 3-[(dimethylamino)methyl]-4-[4-(methylsulfanyl)phenoxy]benzene-1-sulfonamide | |
| 364323-49-9 | 3-[(dimethylamino)methyl]-4-[4-(methylsulfanyl)phenoxy]benzene-1-sulfonamide L-tartrate (1:1) | |
| 941690-55-7 | 3-[(methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide | |
| 1198178-65-2 | (1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethylcyclopropanaminium 4-methylbenzenesulfonate | |
| 1403823-55-1 | 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide di[(2E)-but-2-enedioate] hydrate | |
| 2938 90 10 | 5511-98-8 | acetyldigoxin |
| 2938 90 90 | 81-27-6 | sennoside A |
| 128-57-4 | sennoside B | |
| 517-43-1 | mixture of sennoside A and B | |
| 8024-48-4 | casanthranol | |
| 52730-36-6 | sennoside A, calcium salt | |
| 52730-37-7 | sennoside B, calcium salt | |
| 104443-57-4 | 1-O-[O-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1,4)-O-(N-acetyl-alpha-neuraminosyl)-(2,3)-O-beta-D-galactopyranosyl-(1,4)-beta-D-glucopyranosyl]ceramide | |
| 104443-62-1 | 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2,3)-O-[O-beta-D-galactopyranosyl-(1,3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1,4)]-O-beta-D-galactopyranosyl-(1,4)-beta-D-glucopyranosyl]ceramide | |
| 196085-62-8 | N-{[(1R,2R)-1-[O-(N-acetyl-alpha-neuraminosyl)-(2,3)-O-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1,4)-O-beta-D-galactopyranosyl-(1,4)-beta-D-glucopyranosyloxymethyl]-2-hydroxy-3-formylpropyl}stearamide | |
| 52730-36-6,52730-37-7 | mixture of sennoside A and B, calcium salts | |
| 2939 11 00 | 41444-62-6 | codeine phosphate hemihydrate |
| 2939 19 00 | 6429-04-5 | (RS)-tetrahydropapaverine hydrochloride |
| 54417-53-7 | (R)-1,2,3,4-tetrahydropapaverine hydrochloride | |
| 2939 20 00 | 123599-79-1 | [(2-methyl-1-propionyloxypropoxy)(4-phenylbutyl)phosphinoyl]acetic acid—cinchonidine (1:1) |
| 467430-13-3 | 2-[2-methyl-1-(propionyloxy)propoxy]-2-[(4-phenylbutyl)phosphinoyl]acetic acid, (9R)-cinchonan-9-ol salt (1:1) | |
| 2939 79 90 | 51-55-8 | atropine |
| 92-13-7 | pilocarpine | |
| 477-29-2 | colchicoside | |
| 7689-03-4 | (4S)-4-ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | |
| 16589-24-5 | 4-[1-hydroxy-2-(methylamino)ethyl]phenol—L-tartaric acid (2:1) | |
| 2940 00 00 | 50-69-1 | D-ribose |
| 533-67-5 | 2-deoxy-D-erythropentose | |
| 604-69-3 | 1,2,3,4,6-penta-O-acetyl-β-D-glucopyranose | |
| 4132-28-9 | 2,3,4,6-tetra-O-benzyl-D-glucose | |
| 6564-72-3 | 2,3,4,6-tetra-O-benzyl-D-glucopyranose | |
| 13035-61-5 | 1,2,3,5-tetraacetyl-beta-D-ribofuranose | |
| 24259-59-4 | L-ribose | |
| 80312-55-6 | 2,3,4,6-tetra-O-benzyl-1-O-(trimethylsilyl)-beta-D-glucose | |
| 141256-04-4 | 1-(28-{O-D-apio-beta-D-furanosyl-(1,3)-O-beta-D-xylopyranosyl-(1,4)-O-6-deoxy-alpha-L-mannopyranosyl)-(1,2)-4-O-[5-(5-alpha-L-arabinofuranosyloxy-3-hydroxy-6-methyloctanoyloxy)-3-hydroxy-6-methyloctanoyl]-6-deoxy-beta-D-galactopyranosyloxy}-16-alpha-hydroxy-23-beta,28-dioxoolean-12-en-3-beta-yl)-O-beta-D-galactopyranosyl-(1,2)-O-beta-D-xylopyranosyl-(1,3)-beta-D-glucopyranosiduronic acid | |
| 182410-00-0 | beta-cyclodextrin sulfobutyl ethers, sodium salts | |
| 270071-40-4 | benzyl 2,6-dimethoxy-4-{(5R,5aR,8aR,9S)-6-oxo-9-[(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)oxy]-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl}phenyl carbonate | |
| 471863-88-4 | 2,3-di-O-benzyl-4,6-O-((1R)-ethylidene)-D-xylo-hexopyranose | |
| 473799-30-3 | (5S,5aS,9S)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 2,3-di-O-benzyl-4,6-O-[(1R)-ethylidene]-β-D-glucopyranoside | |
| 647834-15-9 | 2-(4-methoxybenzyl)thiophen-3-yl β-D-glucopyranoside | |
| 2941 90 00 | 13292-22-3 | 3-formylrifamycin |
| 14487-05-9 | rifamycin O | |
| 54122-50-8 | dicyclohexylammonium (7R)-3-(acetoxymethyl)-7-[2-({(3R)-3-[(tert-butoxycarbonyl)amino]-3-carboxypropyl}amino)-2-oxoethyl]-3,4-didehydrocepham-4-carboxylate, or cephalosporin D, dicyclohexylamine salt | |
| 76610-92-9 | (6R,7R)-7-({N-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-D-threonyl}amino)-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | |
| 3002 12 00 | 42617-41-4 | blood-coagulation factor XIVa |
| 116638-33-6 | SC-59735 |
| CN Code | CAS RN | Name |
|---|---|---|
| 3003 90 00 | 195993-11-4 | hemocyanins, megathura crenulata, reaction products with 1-O-[O-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1,4)-O-(N-acetyl-alpha-neuraminosyl)-(2,3)-O-beta-D-galactopyranosyl-(1,4)-beta-D-glucopyranose |
| 3006 30 00 | 155773-56-1 | ferristene |
| 3507 90 90 | 8055-80-9 | fibrinuclease, powder |
| 9001-63-2 | lysozyme | |
| 9002-12-4 | urate oxidase | |
| 9003-98-9 | deoxyribonuclease | |
| 3824 99 | 41201-60-9 | alpha-(6-fluoro-2-methylinden-3-yl)-p-tolyl methyl sulfide, in the form of a solution in toluene |
| 78441-62-0 | 4-(2-aminoethylthiomethyl)-1,3-thiazol-2-ylmethyl(dimethyl)amine, in the form of a solution in toluene | |
| 3824 99 64 | 0-00-0 | intermediate concentrate obtained from a genetically modified Escherichia coli fermentation medium, containing human granulocyte-macrophage colony-stimulating factor; for use in the manufacture of medicaments of HS heading 3002 |
| 0-00-0 | intermediate concentrate obtained from a genetically modified Escherichia coli fermentation medium, containing human interferon alpha-2b; for use in the manufacture of medicaments of HS heading 3002 | |
| 0-00-0 | intermediate concentrates obtained from a Micromonospora inyoensis fermentation medium used for the manufacture of the antibiotics sisomicin (INN) and netilmicin (INN) | |
| 0-00-0 | intermediate concentrates obtained from a Micromonospora purpurea fermentation medium used for the manufacture of the antibiotics gentamicin sulfate (INNM) and isepamicin (INN) | |
| 0-00-0 | potassium clavulanate—microcrystalline cellulose (1:1) | |
| 0-00-0 | potassium clavulanate—silicon dioxide (1:1) | |
| 0-00-0 | potassium clavulanate—sucrose (1:1) | |
| 330-95-0 | 1,3-bis(4-nitrophenyl)urea–4,6-dimethylpyrimidin-2-ol (1:1) | |
| 3824 99 92 | 30165-96-9 | 4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine, toluene solution |
| 38345-66-3 | (2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-ol, toluene solution | |
| 78834-75-0 | ethyl 7-chloro-2-oxoheptanoate, in the form of a solution in toluene | |
| 84449-81-0 | 4-[2-(piperidin-1-yl)ethoxy]benzoyl chloride hydrochloride, 1,2-dichloroethane solution | |
| 127852-28-2 | (1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethan-1-ol, acetonitrile solution | |
| 170277-77-7 | (3S)-3-[2-(mesyloxy)ethoxy]-4-(trityloxy)butyl methanesulfonate, dimethylformamide solution | |
| 3907 29 20 | 1350810-60-4 | poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy, diester with 21N 6,21′N 6-[[(N 2,N 6-dicarboxy-L-lysyl-β-alanyl)imino]bis(1-oxo-2,1-ethanediyl)]bis[N-acetylglycyl-L-leucyl-L-tyrosyl-L-alanyl-L-cysteinyl-L-histidyl-L-methionylglycyl-L-prolyl-L-isoleucyl-L-threonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cysteinyl-L-glutaminyl-L-prolyl-L-leucyl-L-arginyl-N-methylglycyl-L-lysinamide] cyclic (6→15), (6′→15′) bis(disulfide) |
| 3911 90 | 162430-94-6 | 1,6-hexanediamine, polymer with 1,10-dibromodecane |
[SECTION III]
[ANNEX 7]
SECTION IV
FAVOURAΒLE TARIFF TREATMENT ΒY REASON OF THE NATURE OF THE GOODS
ANNEX 8
GOODS UNFIT FOR CONSUMPTION
ANNEX 8
GOODS UNFIT FOR CONSUMPTION
(List of denaturants)
Denaturation of goods unfit, rendered unfit or denatured under a CN code making reference to the present provisions shall be done by means of one of the denaturants referred to in column 4, used in the quantities indicated in column 5.
| Order No | CN code | Description | Denaturant | Denaturant |
|---|---|---|---|---|
| Name | Minimum quantity to be used (in g) per 100 kg of denatured product | |||
| (1) | (2) | (3) | (4) | (5) |
| 1 | 0408 | Birds' eggs, not in shell, and egg yolks, fresh, dried, cooked by steaming or by boiling in water, moulded, frozen or otherwise preserved, whether or not containing added sugar or other sweetening matter | Spirit of turpentine | 500 |
| Essence of lavender | 100 | |||
| Oil of rosemary | 150 | |||
| Birch oil | 100 | |||
| – Egg yolks: | ||||
| 0408 11 | – – Dried: | Fish meal of subheading 2301 20 00 , having a characteristic odour and containing by weight in the dry matter at least: — 62,5 % crude protein and — 6 % crude lipids (fatty matter) | 5 000 | |
| 0408 11 20 | – – – Unfit for human consumption | |||
| 0408 19 | – – Other: | |||
| 0408 19 20 | – – – Unfit for human consumption | |||
| – Other: | ||||
| 0408 91 | – – Dried: | |||
| 0408 91 20 | – – – Unfit for human consumption | |||
| 0408 99 | – – Other: | |||
| 0408 99 20 | – – – Unfit for human consumption | |||
| 2 | 1106 | Flour, meal and powder of the dried leguminous vegetables of heading 0713 , of sago or of roots or tubers of heading 0714 or of the products of Chapter 8: | Fish oil or fish liver oil, filtered but not deodorised or decolorised, with no additives | 1 000 |
| 1106 20 | – Of sago or of roots or tubers of heading 0714 : | Fish meal of subheading 2301 20 00 , having a characteristic odour and containing by weight in the dry matter at least: | 5 000 | |
| 1106 20 10 | – – Denatured | — 62,5 % crude protein and — 6 % crude lipids (fatty matter) | ||
| Order No | CN code | Description | Denaturant | Denaturant |
| --- | --- | --- | --- | --- |
| Name | Name | |||
| Chemical name or description | Common name | |||
| (1) | (2) | (3) | (4) | (4) |
| 3 | 2501 00 | Salt (including table salt and denatured salt) and pure sodium chloride, whether or not in aqueous solution or containing added anti-caking or free-flowing agents; sea water: | Sodium salt of 4-sulphobenzeneazo-resorcinol, or 2,4-dihydroxyazobenzene-4-sulphonic acid (colour: yellow) | Chrysoine S |
| – Salt (including table salt and denatured salt) and pure sodium chloride, whether or not in aqueous solution or containing added anti-caking or free-flowing agents: | Disodium salt of 1-(4-sulpho-1-phenylazo)-4-aminobenzene-5-sulphonic acid (colour: yellow) | Fast yellow AB | ||
| – – Other: | ||||
| 2501 00 51 | – – – Denatured or for industrial uses (including refining) other than the preservation or preparation of foodstuffs for human or animal consumption | Tetrasodium salt of 1-(4-sulpho-1-naphthylazo)-2-naphthol-3,6,8-trisulphonic acid (colour: red) | Ponceau 6 R | |
| Tetrabromofluorescein (colour: fluorescent yellow) | Eosine | |||
| Naphthalene | Naphthalene | |||
| Powdered soap | Powdered soap | |||
| Sodium or potassium dichromate | Sodium or potassium dichromate | |||
| Iron oxide containing not less than 50 % of Fe2O3 by weight. The iron oxide should be dark red to brown and should take the form of a fine powder of which at least 90 % passes through a sieve having a mesh of 0,10 mm | Iron oxide | |||
| Sodium hypochlorite | Sodium hypochlorite | |||
| Order No | CN code | Description | Denaturant | Denaturant |
| --- | --- | --- | --- | --- |
| Name | Minimum quantity to be used (in g) per 100 kg of denatured product | |||
| (1) | (2) | (3) | (4) | (5) |
| 4 | 3502 | Albumins (including concentrates of two or more whey proteins, containing by weight more than 80 % whey proteins, calculated on the dry matter), albuminates and other albumin derivatives: | Oil of rosemary (for liquid albumins only) | 150 |
| Crude oil of camphor (for liquid and solid albumins) | 2 000 | |||
| White oil of camphor (for liquid and solid albumins) | 2 000 | |||
| Sodium azide (for liquid and solid albumins) | 100 | |||
| Diethanolamine (for solid albumins only) | 6 000 | |||
| – Egg albumin: | ||||
| 3502 11 | – – Dried: | |||
| 3502 11 10 | – – – Unfit, or to be rendered unfit, for human consumption | |||
| 3502 19 | – – Other: | |||
| 3502 19 10 | – – – Unfit, or to be rendered unfit, for human consumption | |||
| 3502 20 | – Milk albumin, including concentrates of two or more whey proteins: | |||
| 3502 20 10 | – – Unfit, or to be rendered unfit, for human consumption | |||
| 3502 90 | – Other: | |||
| – – Albumins, other than egg albumin and milk albumin (lactalbumin): | ||||
| 3502 90 20 | – – – Unfit, or to be rendered unfit, for human consumption |
ANNEX 9
CERTIFICATES
ANNEX 9
CERTIFICATES
1. General provisions
Provided that a certificate reproduced in this Annex is presented, favourable tariff treatment by reason of their nature, quality or authenticity of goods shall be granted for the following products:
- — fresh table grapes of heading ex 0806,
- — tobacco of heading ex 2401,
- — nitrate of headings ex 3102 and 3105.
2. Provisions concerning certificates
Layout of the certificates
The certificates shall correspond to the specimens reproduced in this Annex.
The certificates shall be printed and completed in one of the official languages of the European Union and, where appropriate, in an official language of the exporting country.
Certificates measure approximately 210 × 297 millimetres, the paper used shall be white paper weighing at least 40 g/m2.
Endorsement and issuing of certificates
Certificates must be duly endorsed by showing the place and date of issue and by bearing the stamp of the issuing body of the exporting country and the signature of the person or persons empowered to sign it.
Certificates shall be issued by one of the bodies listed in the table below provided that this body:
- — is recognised as such by the exporting country,
- — undertakes to verify the particulars shown in certificates,
- — undertakes to provide the Commission and Member States, on request, with all appropriate information to enable an assessment to be made of the particulars shown in the certificates.
The exporting country shall send the Commission specimens of the stamps used by their issuing body or bodies and authorised offices.
The Commission shall communicate this information to the customs authorities of the Member States.
Validity of certificates
The period of validity of the certificate is 10 months and in the case of tobacco 24 months, running from the date of issue.
Split consignment
Where a consignment is split, the original certificate shall be photocopied for each part of the consignment. The photocopies and the original certificate shall be presented to the competent customs office. Each photocopy shall indicate the name and address of the consignee and be marked in red ‘Extract valid for … kg’ (in figures and letters) together with the place and date of the splitting. These statements shall be authenticated by the customs office stamp and the signature of the customs official responsible. Particulars relating to the splitting of the consignment shall be entered on the original certificate, which shall be retained by the customs office concerned.
List of bodies which may endorse certificates177
Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.
This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence.
EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.